Cargando…
Recent progress of aptamer‒drug conjugates in cancer therapy
Aptamers are single-stranded DNA or RNA sequences that can specifically bind with the target protein or molecule via specific secondary structures. Compared to antibody-drug conjugates (ADC), aptamer‒drug conjugate (ApDC) is also an efficient, targeted drug for cancer therapy with a smaller size, hi...
Autores principales: | He, Jiaxuan, Duan, Qiao, Ran, Chunyan, Fu, Ting, Liu, Yuan, Tan, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150127/ https://www.ncbi.nlm.nih.gov/pubmed/37139427 http://dx.doi.org/10.1016/j.apsb.2023.01.017 |
Ejemplares similares
-
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
por: Li, Yongshu, et al.
Publicado: (2022) -
Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy
por: Liu, Qiaoling, et al.
Publicado: (2014) -
Automated
Modular Synthesis of Aptamer–Drug
Conjugates for Targeted Drug Delivery
por: Wang, RuoWen, et al.
Publicado: (2014) -
Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016) -
Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
por: Kim, Do-Hun, et al.
Publicado: (2021)